name: 4-(4-((2,4-Dioxothiazolidin-5-ylidene)methyl)-2-methoxyphenoxy)-3-(trifluoromethyl)benzonitrile, Career opportunities within science and technology are seeing unprecedented growth across the world, and those who study chemistry or another natural science at university now have increasingly better career prospects. In a article, 1055361-35-7, molcular formula is C19H11F3N2O4S, introducing its new discovery.
The compounds of the invention are antagonists of MDM2 and/or MDMX, with excellent specificity for MDM2 and/or MDMX over other proteins. Several analogs demonstrate selective binding affinity to MDMX over MDM2. The disclosed compounds can therefore regulate p53 activity and treat a variety of cancers. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
In the meantime we’ve collected together some recent articles in this area about 1055361-35-7 to whet your appetite. Happy reading!
Reference：
Quinuclidine – Wikipedia,
Quinuclidine | C7H847N | ChemSpider